Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

LYFAX vs. FTXH: which is better?

Bottom line

LYFAX vs FTXH: the short answer

LYFAX (AlphaCentric Life Sciences and Healthcare Fund) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both mutual funds.

FTXH is cheaper at 0.6% vs 1.66% — a difference of $106 a year per $10,000 invested.

Over five years, FTXH returned +6.5% a year vs +4.1% for LYFAX.

LYFAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

LYFAX vs FTXH side by side

LYFAXFTXH
TypeMutual fundETF
Fund familyMutualFirst Trust
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.66%0.6%
Annual cost per $10k$166$60
10-yr cost on $10k (prospectus)$3,039—
Max front load5.75%None
12b-1 fee0.25%0%
1-yr return+20.6%+24.0%
5-yr return (annualized)+4.1%+6.5%
10-yr return (annualized)——
Best quarter+27.5%+18.3%
Worst quarter−11.9%−17.4%
Net assets (fund)$46.6M$36.2M
Number of holdings6251
Portfolio turnover107%35%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearLYFAXFTXHDifference
2025+27.9%+24.0%+3.9%
2024−0.4%+3.0%−3.4%
2023+6.9%−1.4%+8.3%
2022−1.1%+2.5%−3.6%
2021−3.6%+6.1%−9.7%
2020+54.4%+10.9%+43.6%

Source: Fund prospectus bar charts

Holdings overlap

8 of LYFAX's top 25 holdings also appear in FTXH's top 25.

Shared top holdings
HoldingLYFAXFTXH
Gilead Sciences Inc5.53%2.89%
Vertex Pharmaceuticals Inc5.33%3.41%
Neurocrine Biosciences Inc3.51%1.37%
Incyte Corp3.51%2.39%
Abbvie Inc1.95%7.39%
Amgen Inc1.83%3.18%
Biogen Inc1.80%3.84%
Halozyme Therapeutics Inc1.58%1.21%

Source: SEC Form N-PORT

LYFAX top 10

  1. Gilead Sciences Inc — 5.53%
  2. Vertex Pharmaceuticals Inc — 5.33%
  3. Astrazeneca Plc — 4.63%
  4. First American Funds Inc — 4.26%
  5. Roivant Sciences Ltd — 3.67%
  6. Argenx Se — 3.59%
  7. Neurocrine Biosciences Inc — 3.51%
  8. Incyte Corp — 3.51%
  9. Axsome Therapeutics Inc — 3.43%
  10. Apogee Therapeutics Inc — 3.28%

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

FAQ

What is the difference between LYFAX and FTXH?
LYFAX (AlphaCentric Life Sciences and Healthcare Fund) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both mutual funds. FTXH is cheaper at 0.6% vs 1.66% — a difference of $106 a year per $10,000 invested.
Which is cheaper, LYFAX or FTXH?
FTXH has the lower expense ratio (0.6%).
Should I own both LYFAX and FTXH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.